Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain × Doxycycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 3 Immunoglobulin Light-chain Amyloidosis 3 Breast Neoplasms 3 Mycosis Fungoides 2 Lymphoma, Non-Hodgkin 2 Colorectal Neoplasms 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Tuberous Sclerosis 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Pleural Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Neurofibromatosis 2 1 Neoplasms, Second Primary 1 Myoma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lymphangioleiomyomatosis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Surveys and Questionnaires 14 Acupuncture Therapy 14 Fentanyl 12 Acetaminophen 12 Lidocaine 11 Analgesia 11 Morphine 10 Ketamine 10 Therapeutics 9 Ropivacaine 9 Methadone 9 Bupivacaine 9 Psychiatric Rehabilitation 8 Oxycodone 7 Hydromorphone 7 Water 5 Radiotherapy 5 Music Therapy 5 Methods 5 Early Intervention, Educational 5 Control Groups 5 Zoledronic Acid 4 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Saline Solution 4 Electroacupuncture 4 Colonoscopy 4 Calcium Dobesilate 4 Analgesics, Opioid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡